Characterisation Of The Tumour Suppressor Function Of Caspase-2
Funder
National Health and Medical Research Council
Funding Amount
$605,096.00
Summary
Aberrant cell death (apoptosis) is associated with many diseases including cancer. Apoptosis is mediated by a group of enzymes called caspases. Recently we have discovered that one of these enzymes, caspase-2, acts as a tumour suppressor. We now wish to validate this finding in several preclinical models of cancer and understand precisely how caspase-2 works to safeguard cells against cancer development. These studies will help better understand cancer and ways to treat it.
Apoptosis And Autophagy In Developmentally Programmed Cell Death
Funder
National Health and Medical Research Council
Funding Amount
$502,437.00
Summary
Cell death is essential for sculpting tissues and organs in developing foetus and deregulated cell death results in many diseases. To treat disorders that result from aberrant cell death, we need to understand the control of cell death during development. We will use a vinegar fly model to study cell death modalities in development. By doing this we hope to uncover new knowledge important for human biology and identify new molecules that may be important for understanding and treating disease.
Targeting Of The APC Tumour Suppressor To Mitochondria: Implications For APC Regulation And Cellular Function
Funder
National Health and Medical Research Council
Funding Amount
$390,116.00
Summary
Inherited mutations in the APC gene cause colon cancer, and kills 4,700 Australians every year. About 1 in 21 Australians develop colorectal cancer by the age of 75. APC mutations change cells in different ways, triggering the cancer process. We have discovered a new pathway, involving altered movement of APC to mitochondria in tumour cells. This study will investigate how this cancerous change may help our understanding of colon cancer progression.
Characterization Of HLS5, A Novel Tumor Suppressor Gene
Funder
National Health and Medical Research Council
Funding Amount
$406,980.00
Summary
HLS5 is a novel gene that we recently discovered in our laboratory. Preliminary investigations suggest that HLS5 is similar to a family of genes which act as DNA regulators. We have shown that HLS5 is found on a region of chromosome 8 which is often deleted in human cancers, suggesting that HLS5 is a new tumour suppressor gene i.e.. damage to this gene may be responsible for the formation of certain types of cancer (specifically breast and prostate). Other evidence to support the claim that HLS5 ....HLS5 is a novel gene that we recently discovered in our laboratory. Preliminary investigations suggest that HLS5 is similar to a family of genes which act as DNA regulators. We have shown that HLS5 is found on a region of chromosome 8 which is often deleted in human cancers, suggesting that HLS5 is a new tumour suppressor gene i.e.. damage to this gene may be responsible for the formation of certain types of cancer (specifically breast and prostate). Other evidence to support the claim that HLS5 is a tumour suppressor gene comes from the proteins it associates with these partner molecules are involved in DNA repair or DNA regulation. When we introduced HLS5 into cancer cells, it slowed their growth and reduced their ability to form tumours. The aim of this project therefore, is to undertake a detailed analyses of the HLS5 gene and to determine the function of its protein product. A combination of approaches will be used in this study. We will: (i) alter the amount of HLS5 expression in cancer cells, (ii) characterize the proteins which bind to HLS5, (iii) determining where HLS5 localizes in the cell, (iv) analyze mice with lack the gene for HLS5, (v) assess the involvement of HLS5 in a human leukemia (vi) analyze HLS5 messenger RNA which produces the protein, and (vii) determining the structure of HLS5 protein. These studies should provide valuable information on how HLS5 functions, as well as its role in cancer formation.Read moreRead less
Molecular Characterisation Of Lipid Droplet Function
Funder
National Health and Medical Research Council
Funding Amount
$496,446.00
Summary
Fat is stored inside cells in spherical structures called lipid droplets. The accumulation of fat within lipid droplets underlies obesity. This project aims to understand how fat is stored within lipid droplets and how it is released when energy is required. In particular, we will look at two types of protein which move to lipid droplets under certain energy conditions and attempt to unravel how these proteins control fat storage and release. The first protein we will study, caveolin, normally a ....Fat is stored inside cells in spherical structures called lipid droplets. The accumulation of fat within lipid droplets underlies obesity. This project aims to understand how fat is stored within lipid droplets and how it is released when energy is required. In particular, we will look at two types of protein which move to lipid droplets under certain energy conditions and attempt to unravel how these proteins control fat storage and release. The first protein we will study, caveolin, normally associates with regions of the cell surface but moves to lipid droplets when cells are fed lipids. Mice which lack this protein eat more food but remain leaner than normal mice. Understanding how caveolin moves to lipid droplets and how it controls fat accumulation will therefore provide new insights into obesity and conditions associated with obesity, such as diabetes. The second protein to be studied, Rab18, is a member of a protein family which controls membrane movement within cells. Rab18 moves to lipid droplets when lipid release is stimulated. Therefore studies of Rab18 can provide new insights into the way lipids are released from fat tissue under conditions of starvation. The project will provide fundamental new insights into the basic mechanisms by which we store energy and the energy imbalances which cause obesity and related diseases.Read moreRead less
Regulated Shuttling Of Beta-catenin And IQGAP1 Between Nucleus And Plasma Membrane In Migrating Cells
Funder
National Health and Medical Research Council
Funding Amount
$511,703.00
Summary
Inherited gene mutations that cause colon cancer kill 4,700 Australians every year. About 1 in 21 Australians develop colorectal cancer by age 75. Activation of the beta-catenin protein is a critical switch in the path to colon cancer. We discovered that beta-catenin, and another protein it interacts with called IQGAP1, move between different cellular compartments. We plan to study this process in more detail, as it relates to how beta-catenin works and to understanding its role in cancer.
Regulation Of Beta-catenin Localisation And Its Role In Tumour Cell Migration
Funder
National Health and Medical Research Council
Funding Amount
$271,758.00
Summary
Colon cancer and melanoma are a major health problem and a cause of many cancer-associated deaths. Germ-line mutations in the genes encoding beta-catenin, APC and Axin increase the risk of activating beta-catenin and initiating the progression of colon cancer. A proportion of melanomas correlate with mutation of the beta-catenin gene. The beta-catenin protein is multi-functional; it can work at the outer cell membrane to help cells adhere to one another in an orderly manner, or it can move into ....Colon cancer and melanoma are a major health problem and a cause of many cancer-associated deaths. Germ-line mutations in the genes encoding beta-catenin, APC and Axin increase the risk of activating beta-catenin and initiating the progression of colon cancer. A proportion of melanomas correlate with mutation of the beta-catenin gene. The beta-catenin protein is multi-functional; it can work at the outer cell membrane to help cells adhere to one another in an orderly manner, or it can move into the nucleus where it is involved in activating genes that trigger cancer progression. We are interested in a novel aspect of beta-catenin localisation, when it is present at flexible parts of the cell membrane which are usually associated with active cell migration. In this study we aim to determine whether a fraction of membrane-bound beta-catenin contributes to cell movement or tumour cell invasion. We also will extend our study of the intracellular movement of beta-catenin, to understand how its movement out of the nucleus is regulated by different modifications of the protein, or by damage caused to DNA. This information will increase our understanding of beta-catenin regulation and function, and if successful may lead to identifying new pathways that could be targeted to alter beta-catenin action in cancer cells.Read moreRead less
Regulation Of Cell Death And Proliferation By Histone Demethylases
Funder
National Health and Medical Research Council
Funding Amount
$521,105.00
Summary
Turning genes 'on' and 'off' is essential for normal functioning of cells in the body. Modifications to chromatin (DNA-protein complexes that make up the chromosomes) by some enzymes regulate this switch. This project will identify enzymes that modulate chromatin to control gene expression during cell death and proliferation to maintain cell homeostasis. The study of these enzymes will be important in better understanding of cancer development and in discovering new targets for cancer therapy.
Function And Regulation Of ATM: Mechanistic Studies
Funder
National Health and Medical Research Council
Funding Amount
$455,250.00
Summary
The human genetic disorder ataxia-telangiectasia is characterised by neurodegeneration, immunodeficiency, radiosensitivity and a very high risk for development of cancer. The gene product defective in this syndrome, ATM, was identified in 1995 and since then its role in protecting the cell against genetic damage has been investigated in some detail. The ATM protein is a very large molecule and to date only one functional region has been described. It is very likely that other regions of the mole ....The human genetic disorder ataxia-telangiectasia is characterised by neurodegeneration, immunodeficiency, radiosensitivity and a very high risk for development of cancer. The gene product defective in this syndrome, ATM, was identified in 1995 and since then its role in protecting the cell against genetic damage has been investigated in some detail. The ATM protein is a very large molecule and to date only one functional region has been described. It is very likely that other regions of the molecule will be important in its function in the cell. This project is designed to investigate the importance of other domains in the protein and also what it is that causes ATM to be activated. We have developed a methodology which allows us to introduce changes anywhere in the ATM gene and then test the effects of these changes in a biological read-cut assay. This approach will enable us to ascribe functional significance to any region of ATM. We will focus on regions where we have some preliminary evidence for activity. Finally we will carry out a mechanistic study to see how ATM is activated. These data will be useful in future design of molecules to interfere with the function of ATM in applications designed to make tumours more receptive to radiotherapy.Read moreRead less
Role Of Sphingosine Kinase 1 In PP2A-associated Tumorigenesis
Funder
National Health and Medical Research Council
Funding Amount
$522,994.00
Summary
Defects in protein phosphatase 2A (PP2A) are widely associated with the development of solid tumors and leukemia. The precise mechanisms whereby defects in PP2A lead to cancer, however, remain undefined. We have recently identified that the oncogenic protein sphingosine kinase 1 (SK1) as a target of PP2A. In this study we will examine the role of SK1 in PP2A-associated cancers. Successful outcomes in these studies will establish SK1 as a target for therapeutic intervention in these cancers.